IMT Manesar, India

Jeevan Verma



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • IMT Manesar, IN (2019 - 2021)
  • Manesar, IN (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Jeevan Verma: Pioneering GPR119 Agonists

Introduction

Jeevan Verma, an esteemed inventor based in IMT Manesar, India, has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of five patents, he has dedicated his career to advancing medical research and innovation.

Latest Patents

Among his notable inventions are two recent patents centered on GPR119 agonist compounds. The first patent involves novel compounds of formula (I), detailing a process for their preparation and a composition comprising these compounds. The second patent further expands on this with compounds also identified as GPR119 agonists, offering comprehensive details on their compositions and methods of preparation.

Career Highlights

Jeevan currently works at Mankind Pharma Ltd., a leading name in the pharmaceutical sector. His work has focused on developing novel therapeutic solutions that can enhance treatment outcomes for various medical conditions. His innovative spirit and technical expertise have positioned him as a key player in his field.

Collaborations

Throughout his career, Jeevan has collaborated with notable professionals in the industry, including Rakesh Ishwar Patil and Santosh Kumar Rai. These collaborations have enabled him to combine diverse expertise, fostering an environment of creativity and innovation.

Conclusion

Jeevan Verma stands out as a dedicated inventor whose patent contributions in the area of GPR119 agonists exemplify his commitment to medical advancement. His work not only enhances the capabilities of Mankind Pharma Ltd. but also contributes meaningfully to the broader landscape of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…